• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of epidermal growth factor receptor in normal ovary and in ovarian tumors.

作者信息

Stewart C J, Owens O J, Richmond J A, McNicol A M

机构信息

Department of Pathology, Royal Infirmary, Glasgow, Scotland.

出版信息

Int J Gynecol Pathol. 1992 Oct;11(4):266-72. doi: 10.1097/00004347-199210000-00004.

DOI:10.1097/00004347-199210000-00004
PMID:1399232
Abstract

Increased expression of epidermal growth factor (EGF) receptor has been recorded in many types of human tumors and has been associated with reduced survival in ovarian carcinoma. The purpose of this study was to examine the immunocytochemical distribution of the EGF receptor in normal ovaries (n = 30) and in ovarian tumors (n = 126). Staining was observed in two normal ovaries, in the granulosa cells of a developing follicle, and in surface epithelium. Forty-seven of 103 malignant common epithelial tumors were immunopositive. Staining was usually focal, always confined to the neoplastic epithelium, and showed a cytoplasmic distribution. There was a slight trend for increased EGF receptor expression in more advanced common epithelial malignancies, but this was not statistically significant. No correlation between immunoreactivity and histological subtype or grade of tumor was seen. A few other tumors were also examined: one each of Brenner tumor, mature teratoma, mature teratoma with squamous carcinoma, borderline serous tumor and fibroma; all were immunopositive.

摘要

相似文献

1
Expression of epidermal growth factor receptor in normal ovary and in ovarian tumors.
Int J Gynecol Pathol. 1992 Oct;11(4):266-72. doi: 10.1097/00004347-199210000-00004.
2
Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.c-erbB-2蛋白和表皮生长因子受体在卵巢正常表面上皮、表面包涵囊肿及常见上皮性肿瘤中的免疫组织化学定位
Virchows Arch A Pathol Anat Histopathol. 1992;421(5):393-400. doi: 10.1007/BF01606911.
3
Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.血小板源性生长因子及其受体在上皮性卵巢肿瘤中的表达及预后意义
Cancer Res. 1993 Oct 1;53(19):4550-4.
4
Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study.表皮生长因子受体在良性和恶性卵巢肿瘤及正常卵巢组织中的表达:一项免疫组织化学研究
J Cancer Res Clin Oncol. 1992;118(4):303-7. doi: 10.1007/BF01208620.
5
Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors.表皮生长因子相关蛋白及表皮生长因子受体在常见上皮性卵巢肿瘤中的表达
Int J Gynecol Pathol. 1997 Jan;16(1):60-8. doi: 10.1097/00004347-199701000-00010.
6
Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.c-ABL、c-KIT和血小板衍生生长因子受体-β在卵巢浆液性癌和正常卵巢表面上皮中的表达。
Cancer. 2003 Aug 15;98(4):758-64. doi: 10.1002/cncr.11561.
7
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor.正常卵巢上皮和卵巢癌中表皮生长因子受体的表达。II. 受体表达与对表皮生长因子反应之间的关系。
Am J Obstet Gynecol. 1991 Mar;164(3):745-50. doi: 10.1016/0002-9378(91)90508-o.
8
Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor.
Am J Obstet Gynecol. 1993 Jan;168(1 Pt 1):71-8. doi: 10.1016/s0002-9378(12)90888-1.
9
An immunohistochemical perspective of PPAR beta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours.过氧化物酶体增殖物激活受体β(PPARβ)及其假定靶点之一丙酮酸脱氢酶激酶1(PDK1)在正常卵巢、卵巢良性和恶性肿瘤中的免疫组化研究。
Br J Cancer. 2008 Apr 22;98(8):1415-24. doi: 10.1038/sj.bjc.6604306. Epub 2008 Mar 18.
10
E-cadherin expression in human epithelial ovarian cancer and normal ovary.E-钙黏蛋白在人上皮性卵巢癌和正常卵巢中的表达。
Int J Cancer. 1997 Jun 20;74(3):275-80. doi: 10.1002/(sici)1097-0215(19970620)74:3<275::aid-ijc7>3.0.co;2-w.

引用本文的文献

1
ARID3B Directly Regulates Ovarian Cancer Promoting Genes.ARID3B直接调控促进卵巢癌的基因。
PLoS One. 2015 Jun 29;10(6):e0131961. doi: 10.1371/journal.pone.0131961. eCollection 2015.
2
ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.ARID3B 诱导肿瘤坏死因子 α 介导的细胞凋亡,而新型 ARID3B 剪接形式则不会诱导细胞死亡。
PLoS One. 2012;7(7):e42159. doi: 10.1371/journal.pone.0042159. Epub 2012 Jul 31.
3
EGFR soluble isoforms and their transcripts are expressed in meningiomas.
表皮生长因子受体可溶性异构体及其转录本在脑膜瘤中表达。
PLoS One. 2012;7(5):e37204. doi: 10.1371/journal.pone.0037204. Epub 2012 May 18.
4
The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.表皮生长因子受体反应性 miR-125a 抑制卵巢癌细胞的间充质形态。
Neoplasia. 2009 Nov;11(11):1208-15. doi: 10.1593/neo.09942.
5
PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.PEA3对于表皮生长因子受体刺激的基质金属蛋白酶的最佳表达以及卵巢肿瘤细胞的侵袭是必需的。
Mol Cancer Res. 2007 May;5(5):413-21. doi: 10.1158/1541-7786.MCR-07-0019. Epub 2007 May 2.
6
Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.c-Raf表达与卵巢癌生存率的关联及其反义寡核苷酸靶向作用
Br J Cancer. 2001 Nov 30;85(11):1753-8. doi: 10.1054/bjoc.2001.2139.
7
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.原发性卵巢癌中表皮生长因子、雌激素和孕激素受体的表达:与临床结局及化疗反应的相关性
Br J Cancer. 1995 Aug;72(2):361-6. doi: 10.1038/bjc.1995.339.